908-575-7350

NJ Center for Tourette Syndrome reappoints Tim Howard to its Board of Directors

NJCTS reappoints Tim Howard to its Board of Directors.

SOMERVILLE, NJ— World-renowned goalkeeper Tim Howard reaffirms his commitment to improving the lives of individuals with Tourette Syndrome by serving on the Board of Directors for the NJ Center for Tourette Syndrome and Associated Disorders, Inc. (NJCTS) for another two-year term. Howard has been associated with NJCTS, the nation’s first Center of Excellence for Tourette Syndrome, since its founding.

Over the years, the North Brunswick, NJ, native has shared his personal experience with Tourette Syndrome (TS)—a misunderstood and misdiagnosed neurological disorder that affects 1 in 100 children, characterized by vocal sounds and motor movements called tics.

“Tim Howard’s partnership with NJCTS was formed when he played for the MetroStars and he publicly announced his TS diagnosis,” said NJCTS Executive Director Faith W. Rice. “We are delighted to have Tim’s continued support and inspiration as we work toward making lives better for individuals and families living with Tourette Syndrome.

Howard has had a stellar career, playing for Major League Soccer’s New York/New Jersey MetroStars, the English Premier League’s Manchester United and Everton Football Club, and the U.S. Men’s National Team. He has just completed a deal to join the Colorado Rapids, returning to Major League Soccer and the United States after 13 years in England. As his star rose, he helped bring Tourette Syndrome awareness to the global stage.

In addition to serving as an NJCTS board member, Howard is also a critical partner in NJCTS’s anti-stigma, Tourette Syndrome awareness platform, The GreaTS. The campaign’s expanded launch is expected to begin in the coming weeks with the launch of the website, www.standwiththegreats.org.

For more information about Tourette Syndrome, NJCTS, and The GreaTS, contact 908-575-7350 or www.njcts.org.

###

NJ Center for Tourette Syndrome & Associated Disorders, Inc.
Collaborative partnerships for the Tourette Syndrome community